Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma
Clinical trial NCT03338959 · COMPLETED
Trial details
- NCT number
- NCT03338959
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-28
- Primary completion
- 2023-06-08
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.